$1.36
-0.08-5.56%
Last update: Oct 30, 7:41 PM
Aardvark Therapeutics Inc (AARD) Stock Price, Quote, News & History
AARDNASDAQ
Aardvark Therapeutics reports Phase 3 data for ARD-101 and prepares to meet with the FDA to discuss lower-dose testing.
You can purchase shares of Aardvark Therapeutics (NASDAQ:AARD) through any online brokerage.
Other companies in Aardvark Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Aardvark Therapeutics has a consensus price target of $10.00.
The stock price for Aardvark Therapeutics (NASDAQ: AARD) is $1.3501 last updated October 30, 2026 at 7:41 PM EDT.
There are no upcoming dividends for Aardvark Therapeutics.
Aardvark Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Aardvark Therapeutics.
Aardvark Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective...
